Pre-clinical evaluation of antiviral activity of nitazoxanide against SARS-CoV-2.

Saved in:
Bibliographic Details
Title: Pre-clinical evaluation of antiviral activity of nitazoxanide against SARS-CoV-2.
Authors: Driouich JS; Unité des Virus Émergents (UVE: Aix-Marseille University -IRD 190-Inserm 1207), Marseille, France. Electronic address: jean-selim.driouich@univ-amu.fr., Cochin M; Unité des Virus Émergents (UVE: Aix-Marseille University -IRD 190-Inserm 1207), Marseille, France., Touret F; Unité des Virus Émergents (UVE: Aix-Marseille University -IRD 190-Inserm 1207), Marseille, France., Petit PR; Unité des Virus Émergents (UVE: Aix-Marseille University -IRD 190-Inserm 1207), Marseille, France., Gilles M; Unité des Virus Émergents (UVE: Aix-Marseille University -IRD 190-Inserm 1207), Marseille, France., Moureau G; Unité des Virus Émergents (UVE: Aix-Marseille University -IRD 190-Inserm 1207), Marseille, France., Barthélémy K; Unité des Virus Émergents (UVE: Aix-Marseille University -IRD 190-Inserm 1207), Marseille, France., Laprie C; Laboratoire Vet-Histo, Marseille, France., Wattanakul T; Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand., Chotsiri P; Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand., Hoglund RM; Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand; Centre for Tropical Medicine and Global Health, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom., Tarning J; Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand; Centre for Tropical Medicine and Global Health, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom., Fraisse L; Drugs for Neglected Diseases initiative, Geneva, Switzerland., Sjö P; Drugs for Neglected Diseases initiative, Geneva, Switzerland., Mowbray CE; Drugs for Neglected Diseases initiative, Geneva, Switzerland., Escudié F; Drugs for Neglected Diseases initiative, Geneva, Switzerland., Scandale I; Drugs for Neglected Diseases initiative, Geneva, Switzerland., Chatelain E; Drugs for Neglected Diseases initiative, Geneva, Switzerland., de Lamballerie X; Unité des Virus Émergents (UVE: Aix-Marseille University -IRD 190-Inserm 1207), Marseille, France., Solas C; Unité des Virus Émergents (UVE: Aix-Marseille University -IRD 190-Inserm 1207), Marseille, France; APHM, Laboratoire de Pharmacocinétique et Toxicologie, Hôpital La Timone, Marseille, France., Nougairède A; Unité des Virus Émergents (UVE: Aix-Marseille University -IRD 190-Inserm 1207), Marseille, France.
Source: EBioMedicine [EBioMedicine] 2022 Aug; Vol. 82, pp. 104148. Date of Electronic Publication: 2022 Jul 11.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2352-3964 (Electronic) Linking ISSN: 23523964 NLM ISO Abbreviation: EBioMedicine Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2352-3964
DOI:10.1016/j.ebiom.2022.104148